PARK2 polymorphisms predict disease progression in patients infected with hepatitis C virus.
Al-Qahtani AA, Al-Anazi MR, Al-Zoghaibi FA, Abdo AA, Sanai FM, Al-Hamoudi WK, Alswat KA, Al-Ashgar HI, Khan MQ, Albenmousa A, Khalak H, Al-Ahdal MN.
Al-Qahtani AA, et al. Among authors: albenmousa a.
Ann Hepatol. 2016 Nov-Dec 2016;15(6):824-833. doi: 10.5604/16652681.1222097.
Ann Hepatol. 2016.
PMID: 27740515
Free article.